In vivo antibacterial activity of diaveridine-sulfonamide combinations.
D000818:Animals; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004285:Dogs; D004927:Escherichia coli Infections / Q000188:drug therapy*; D005260:Female; D007710:Klebsiella Infections / Q000188:drug therapy*; D008297:Male; D011467:Prostate / Q000382:microbiology; D011512:Proteus Infections / Q000188:drug therapy*; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013411:Sulfadiazine / Q000008:administration & dosage / Q000627:therapeutic use*; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D011743:Pyrimidines; D013449:Sulfonamides; D013411:Sulfadiazine